| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |